Drawing for ATTENUVAX

USPTO serial 72299366

ATTENUVAX

Reviewed by CopyMark Law Group

Reg. 0887025Status 710
Filing date
Status date
Registration date
Mar 3, 1970
Examiner
—
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ATTENUVAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher Bolinger

Christopher Bolinger MERCK & CO INC126 East Lincoln AvenueRahway, NJ 07065-0900UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
018MEASLES VACCINE FOR HUMAN USESECTION 8 - CANCELLEDMay 10, 1968

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Mar 3, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 24, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 13, 2012ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 30, 2012ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 6, 2010CORVREVIEW OF CORRESPONDENCE COMPLETE—
Apr 29, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 11, 2010MAILPAPER RECEIVED—
Dec 9, 2009ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 2, 2009ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 4, 2009RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jun 4, 200989AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
May 29, 2009PLGLASSIGNED TO PARALEGAL—
May 26, 2009E89RTEAS SECTION 8 & 9 RECEIVED—
Nov 26, 2008CFITCASE FILE IN TICRS—
Oct 18, 1999RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Sep 8, 19999.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8—
Nov 20, 1989RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Sep 7, 19899.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8—

Frequently asked questions

Related guidance